Indefinite Delivery Contract HHSN268201200014I

Award Date 9/21/12
Last Date to Order 9/23/15
Ultimate Awardee
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) to the New York Stem Cell Foundation, Inc., a non-profit organization, for $6,984,000. The contract supports professional services related to pluripotent stem cell research, with a period of performance from September 21, 2012 to September 23, 2015. Under this multiple-award IDC, the New York Stem Cell Foundation has generated...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS) Office of Logistics and Acquisition Operations to Fujifilm Wako Chemicals U.S.A. Corporation, a subsidiary of FUJIFILM Holdings America Corp. The $0 ceiling value BPA is for the provision of chemicals and laboratory supplies to support biomedical research and testing. Under this BPA, Fujifilm Wako Chemicals has delivered extracellular vesicle isolation kits to the National Heart Lung and...
This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The BPA has a ceiling value of $10,000,000 and runs through December 31, 2025. Under this single-award IDV, Stemcell Technologies Inc. will provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
This indefinite delivery contract was awarded to Cellectis Bioresearch Inc. by the National Heart Lung and Blood Institute, a civilian federal agency, to provide professional support services. The contract is a multiple award, with a ceiling value of $6,984,000.00 and a period of performance through September 23, 2015. The contract aims to procure professional support services related to gene insertion and pluripotent stem cell research, as indicated by the parent master IDIQ contract title...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Xcell Science Incorporated, a woman-owned small business. The contract has a ceiling value of $3,609,000.00 and is a delivery order under the "Gene Insertion - Pluripotent Stem Cells 2012-2017" IDIQ contract. The contract is for SUPPORT- PROFESSIONAL: OTHER services, with a current task order valued at $1,001,068.00 and a completion date of...
This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Fisher Bioservices Inc.'s Clinical Trials Division. The $100,000,000 contract has an ultimate completion date of January 21, 2035 and was awarded on January 22, 2025. The contract is for the storage, monitoring, distribution, and occasional destruction of human biospecimens collected by NICHD as part of its research on child...
This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. federal government, to the prime contractor Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation. The contract, valued at a ceiling of $222,903.87, is for the delivery of laboratory equipment and supplies to support the agency's specialized research and healthcare mission. The award leverages Applied Biosystems' expertise as a manufacturer of genetic...
This indefinite delivery contract was awarded by the National Institute on Drug Abuse, a civilian agency of the U.S. federal government, to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center. The contract, valued at up to $8,561,066.85, is for the development and maintenance of an aged cell bank to support research and development activities. Coriell Institute, a leading provider of biorepository and biospecimen services to the federal government, will be...
This indefinite delivery contract (IDC) was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services, to Affymetrix, Inc., a for-profit manufacturer of goods. The contract is for the provision of laboratory equipment and supplies, with a ceiling value of $423,560.00 and a period of performance ending on July 24, 2012. The contract was a single-award IDC, meaning Affymetrix was the sole awardee. There were no set-asides...

This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell products.

The contract supports the supply of a wide range of specialized cell types derived from iPSCs, such as cardiomyocytes, neurons, astrocytes, hepatocytes, and macrophages. These cell cultures are primarily used to support biomedical research and drug development initiatives across various federal agencies, including the Food and Drug Administration (FDA) and National Institutes of Health (NIH). The contract is a multiple-award, firm-fixed-price vehicle with a ceiling value of $6,984,000. It does not utilize any small business set-asides and has an ultimate completion date of September 23, 2015. Fujifilm Cellular Dynamics has received numerous awards under this contract, often on a sole-source basis, due to the proprietary and specialized nature of its iPSC-derived cell products.

Generated 11/24/24, 9:07 AM